Skip to main
RPRX

Royalty Pharma (RPRX)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Royalty Pharma (RPRX) Stock

About Royalty Pharma (RPRX)

Market cap
Today's volume3
Revenue (TTM)
Avg. daily volume
EBITDA (TTM)
Open$58.95
Price / earnings ratio
Today's range$58.35 - $59.54
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)
Interest coverage
Dividend & yield— (1.58%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Royalty Pharma Stock Rating

What analysts recommend for RPRX stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

Yes, the RPRX stock pays a dividend to its shareholders. The current dividend yield is 1.58%

The target price for RPRX stock is $59.67 based on the average of what a group of analyst think RPRX stock could be worth at a future date. This is not a prediction by Public.com

How to buy RPRX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in RPRX stock

    Navigate to the Explore page. Then, type RPRX into the search bar. When you see RPRX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased RPRX stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

Royalty Pharma Stock Earnings

The value each RPRX share was expected to gain vs. the value that each RPRX share actually gained.

Royalty Pharma (RPRX) reported Q2 2026 earnings per share (EPS) of $1.32, beating estimates of $1.27 by 3.94%. In the same quarter last year, Royalty Pharma's earnings per share (EPS) was $1.14. Royalty Pharma is expected to release next earnings on , with an earnings per share (EPS) estimate of $1.18.

Buy Royalty Pharma (RPRX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.